2.04
price up icon2.51%   0.05
after-market Dopo l'orario di chiusura: 2.01 -0.03 -1.47%
loading

Mainz Biomed N V Borsa (MYNZ) Ultime notizie

pulisher
04:37 AM

Mainz Biomed N.V. Stock Analysis and ForecastStrong return on assets - jammulinksnews.com

04:37 AM
pulisher
03:01 AM

What drives Mainz Biomed N.V. stock priceUnprecedented market success - Autocar Professional

03:01 AM
pulisher
12:18 PM

Does Mainz Biomed N.V. stock pay reliable dividendsFree Stock Market Return Analysis - jammulinksnews.com

12:18 PM
pulisher
Jul 24, 2025

Should I buy Mainz Biomed N.V. stock before earningsHigh-impact stock picks - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Mainz Biomed, CARE announce collaboration agreement - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Mainz Biomed Partners with CARE Diagnostica to Enhance Colorectal Cancer Screening in Germany - Nasdaq

Jul 23, 2025
pulisher
Jul 23, 2025

Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

Mainz Biomed Expands Early Cancer Detection Program to 19 German Health Insurers Through CARE Partnership - Stock Titan

Jul 23, 2025
pulisher
Jul 22, 2025

When the Price of (MYNZ) Talks, People Listen - news.stocktradersdaily.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Mainz Biomed N.V. stockConsistently profitable trades - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Mainz Biomed N.V. a good long term investmentRapid growth trajectories - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Why Mainz Biomed N.V. stock attracts strong analyst attentionFree Long-Term Wealth Growth Plan - beatles.ru

Jul 20, 2025
pulisher
Jul 16, 2025

Mainz Biomed (NASDAQ:MYNZ) Trading Up 7% – Here’s Why - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

Mainz Biomed Half Year 2025 Update: Accelerating FDA - GlobeNewswire

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Mainz Biomed N.V. stock price move sharplyFree Stock Market Expert Consultation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

ARBI(arbipad) News and UpdatesProtected Capital Trading Plan - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Mainz Biomed N.V. stock performs during market volatilityFree Step-by-Step Investment Guide - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Mainz Biomed reviews accomplishments for first half of 2025 - TipRanks

Jul 15, 2025
pulisher
Jul 15, 2025

Mainz Biomed N.V. Announces Key Achievements and Corporate Update for First Half of 2025 - Nasdaq

Jul 15, 2025
pulisher
Jul 15, 2025

Mainz Biomed's Dual Breakthrough: FDA Trial Progress and Revolutionary 95% Accurate Pancreatic Cancer Detection - Stock Titan

Jul 15, 2025
pulisher
Jul 12, 2025

Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants - 富途牛牛

Jul 12, 2025
pulisher
Jun 25, 2025

Mainz Biomed (MYNZ) Secures State Funding for Pancreatic Cancer Project | MYNZ Stock News - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test - FinancialContent

Jun 25, 2025
pulisher
Jun 24, 2025

Mainz Biomed (MYNZ) to Release Quarterly Earnings on Tuesday - Defense World

Jun 24, 2025
pulisher
Jun 21, 2025

Where are the Opportunities in (MYNZ) - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 12, 2025

Mainz Biomed (NASDAQ:MYNZ) Trading Down 1.9% – Here’s What Happened - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

(MYNZ) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 11, 2025
pulisher
Jun 10, 2025

Mainz Biomed (MYNZ) Advances PancAlert Project for Pancreatic Ca - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Mainz Biomed Initiates Feasibility Study Of PancAlert Blood Test For Pancreatic Cancer Detection - Nasdaq

Jun 10, 2025
diagnostics_research WAT
$302.95
price up icon 1.50%
diagnostics_research DGX
$168.55
price down icon 1.95%
$138.90
price down icon 1.53%
diagnostics_research LH
$264.96
price down icon 1.02%
diagnostics_research MTD
$1,263.99
price up icon 0.26%
diagnostics_research A
$120.18
price down icon 0.14%
Capitalizzazione:     |  Volume (24 ore):